Clinical outcomes of weekly adalimumab in refractory non-infectious paediatric uveitis and the role of serum drug levels and anti-adalimumab antibodies - Poll - MDSpire

Clinical outcomes of weekly adalimumab in refractory non-infectious paediatric uveitis and the role of serum drug levels and anti-adalimumab antibodies

  • By

  • Amelia Rees

  • Raheej Khan

  • Jessy Choi

  • Clare Nash

  • Daniel Hawley

  • Sasa Pockar

  • Shiao Wei Wong

  • Guilia Varnier

  • Vinod Sharma

  • Alice Chieng

  • Jane Ashworth

  • May 29, 2026

  • 0 min

Share

Original Source(s)

Clinical outcomes of weekly adalimumab in refractory non-infectious paediatric uveitis and the role of serum drug levels and anti-adalimumab antibodies

  • by Amelia Rees, Raheej Khan, Jessy Choi, Clare Nash, Daniel Hawley, Sasa Pockar, Shiao Wei Wong, Guilia Varnier, Vinod Sharma, Alice Chieng, Jane Ashworth

  • May 29, 2026

Related Content

When Vision Becomes a Casualty of War

Why ophthalmic care and resources are desperately needed in Gaza right now

Robotic Transanal minimally invasive surgery for rectal neoplasms: A systematic review of outcomes and innovations

Fabricated Citations Are Reaching Medical Journals

A large audit of biomedical publications suggests fabricated references are increasingly appearing in peer-reviewed papers — often in ways that are difficult for reviewers and readers to detect.